The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models (Q35058305)
Jump to navigation
Jump to search
scientific article published on October 13, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models |
scientific article published on October 13, 2010 |
Statements
1 reference
The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models (English)
1 reference
The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models (English)
Andrew Thorburn
1 reference
Stephen Leong
1 reference
Sara A. Flanigan
Todd M. Pitts
S. Gail Eckhardt
13 October 2010
1 reference
1 reference
16
1 reference
22
1 reference
5436-5446
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference